Our Services
At MEDOMIX, driven by a commitment to scientific excellence and ongoing technological innovation, we deliver reliable and precise genetic testing services that contribute significantly to enhancing the quality of life for each individual examined.
Choose the test you’re interested in to see detailed information.
Woman | Man
The CardioMDx P4 service offers patients and healthcare professionals a personalized insight into the genetic predisposition to a variety of cardiovascular diseases. Simultaneously, it provides all necessary information regarding response to therapeutic interventions (statins) by analyzing polymorphisms in key pharmacogenes.
Sample: Buccal swab
Methodology: SNP Arrays
Turnaround Time: 30 business days
The PsyPGx service is an innovative pharmacogenetic test designed within the framework of modern psychiatric science. It provides patients and healthcare professionals with a personalized profile of drug metabolism, efficacy, and tolerability of psychiatric medications by analyzing genetic polymorphisms in critical pharmacogenes.
Sample: Buccal swab
Methodology: SNP Arrays
Turnaround Time: 30 business days
Whole Exome Sequencing (WES) for diagnostic purposes is an advanced service that analyzes the entire coding regions of the genome, aiming to detect genetic variants that may explain one or more clinical phenotypes. Leveraging Next Generation Sequencing (NGS) and supported by Artificial Intelligence (AI), this method reveals the majority of genetic information associated with pathological conditions, enabling accurate diagnosis and personalized interventions by healthcare professionals.
The test is available for individuals (Solo) as well as families (Trio).
Sample: Buccal swab
Methodology: Next Generation Sequencing (NGS)
Turnaround time: 45 working days
Whole Genome Sequencing (WGS) is the most comprehensive and innovative genetic testing service an individual can undergo. Its primary aim is to analyze the entire genome to detect genetic variants associated with predisposition to medical conditions, reproductive risk (carrier screening), and pharmacogenomic responses. By harnessing the power of Next Generation Sequencing (NGS) and Artificial Intelligence (AI), WGS MDx unlocks the full spectrum of an individual’s genetic information, providing valuable insight into their overall genetic health profile.
Sample: Buccal swab
Methodology: Next Generation Sequencing (NGS)
Turnaround time: 45 working days
Man | Woman
mir-THYpe full is an innovative molecular test for the precision diagnosis of indeterminate thyroid nodules. mir-THYpe full functions as a molecular classifier of malignancy risk. By analyzing specific microRNA expression profiles, as well as mutations in genes such as BRAF and TERT, it provides a clear "positive" or "negative" result regarding the likelihood of malignancy. In this way, it aids in clinical decision-making, helping to avoid unnecessary surgical interventions.
Recommended for nodules with indeterminate cytology classified as Bethesda III and IV. After consultation, the test can also be performed for nodules classified as Bethesda V.
Sample: FNA slides collected for cytology (No need for a new FNA biopsy)
Turnaround time: 15 business days from the date of receipt by Onkos
Man | Woman
mir-THYpe pre-op is an innovative molecular test for thyroid nodules that assesses the aggressiveness of a nodule classified as suspicious for malignancy (Bethesda V) or malignant (Bethesda VI), based on prognostic molecular markers (predictors of aggressiveness). mir-THYpe pre-op analyzes specific microRNA expression profiles and mutations in critical genes, and personalizes the decision on surgical extent and urgency (e.g., total thyroidectomy and lymph node dissection), ensuring a more personalized surgical plan.
Recommended for nodules classified as Bethesda V and VI.
Sample: FNA slides collected for cytology (No need for a new FNA biopsy)
Turnaround time: 15 business days from the date of receipt by Onkos
